ConductScience.org, home

Trial · NCT04805073

Treatment of Pruritus With Intramuscular Promethazine

NCT04805073, Phase 4, Completed, University of Florida; results first posted 2025-05-04

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Treatment of Pruritus With Intramuscular Promethazine. Trials, record NCT04805073. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04805073

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Treatment of Pruritus With Intramuscular Promethazine
NCT number
NCT04805073
Status
Completed
Phases
Phase 4
Enrollment
72 participants, actual
Lead sponsor
University of Florida
Conditions
Pruritus, Pregnancy Related
Interventions
Promethazine, Placebo
First posted
2021-03-18
Last updated
2025-05-04
Results first posted
2025-05-04
Limitations and caveats
We failed to enroll the planned number of patients due to a variety of factors, including challenges in availability of the study drug coupled with slow enrollment. Over two-thirds of the patients who were screened and were able to be contacted prior to surgery declined to participate. This did not support continuing enrollment.

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDoes the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?Within first 24 hours after cesarean section
Pruritus (itching) will be quantified by the ItchyQuant Scale. The ItchyQuant scale is a 0 -10 scale with 0 denoting no itch and 10, the worst itch possible. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their itching. In the results here we reported any itching (a score greater than zero on the ItchyQuant scale) at 24 hours after surgery in each group.
SecondaryDoes Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?Within first 24 hours post cesarean section
Level of consciousness will be quantified by the RASS Scale. The RASS scale is scored with +4 to -5 scale with +4=combative, 0=alert and calm and -5=unrousable. Participants were asked at 3 different time points (1 hour, 4 hours and 24 hours) after surgery to rate their level of consciousness. In the results here we reported any score not noted to be 0 (alert and calm) at 24 hours after surgery in each group.
SecondaryDoes Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline?Within first 24 hours post cesarean section
We asked patients to rate their sensation of nausea and/or vomiting as none, mild, moderate or severe at 4 time points after cesarean (1 hour, 4 hours and 24 hours after cesarean). Here, we rate any report of nausea and/or vomiting as opposed to no nausea and/or vomiting at 24 hours after cesarean among the patients who had Promethazine and normal saline.

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYDoes the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?Within first 24 hours after cesarean section
Sixty-seven patients completed the protocol; of these, 34 received intramuscular promethazine (IMP) and 33 received intramuscular saline placebo (NS). There was incomplete data for 2 patients who received IMP and 1 patient who received NS.
ParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYDoes Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?Within first 24 hours post cesarean sectionParticipantsCOUNT_OF_PARTICIPANTS
SECONDARYDoes Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline?Within first 24 hours post cesarean sectionParticipantsCOUNT_OF_PARTICIPANTS

Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?PromethazineNo Itching at 24 hour22Participants
Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?PlaceboNo Itching at 24 hour17Participants
Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?PromethazineItching at 24 hour10Participants
Does the Addition of Promethazine Reduce Itching After Spinal Morphine for Cesarean Delivery?PlaceboItching at 24 hour15Participants
Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?PromethazineAlert and Calm at 24 hour32Participants
Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?PlaceboAlert and Calm at 24 hour31Participants
Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?PromethazineNot Alert and Calm at 24 hour0Participants
Does Promethazine Impact Level of Consciousness Compared to Placebo After Cesarean Delivery?PlaceboNot Alert and Calm at 24 hour1Participants
Does Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline?PromethazineNo nausea or vomiting at 24 hours31Participants
Does Promethazine Change Nausea and Vomiting After Cesarean Compared to Normal Saline?PlaceboNo nausea or vomiting at 24 hours32Participants

Participant flow6

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDPromethazine36
Overall StudySTARTEDPlacebo36
Overall StudyCOMPLETEDPromethazine34
Overall StudyCOMPLETEDPlacebo33
Overall StudyNOT COMPLETEDPromethazine2
Overall StudyNOT COMPLETEDPlacebo3

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals6

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityPromethazine034
Total, all-cause mortalityPlacebo033
Total, other adverse eventsPromethazine034
Total, other adverse eventsPlacebo033
Total, serious adverse eventsPromethazine034
Total, serious adverse eventsPlacebo033

Papers18

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
1416128BACKGROUNDPubMed
2043531BACKGROUNDPubMed
3144443BACKGROUNDPubMed
7848959RESULTPubMed
8498418BACKGROUNDPubMed
9350364BACKGROUNDPubMed
11009242BACKGROUNDPubMed
11050519RESULTPubMed
12694022BACKGROUNDPubMed
16597655RESULTPubMed

1 to 10 of 18

See all 18 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons2

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource
Promethazine vs Placebo: deaths from any causeTrial comparisons
Promethazine vs Placebo: serious adverse eventsTrial comparisons

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04805073

GET https://conductscience.org/api/trials/v1/NCT04805073/registered